BioCentury | Mar 3, 2021
Finance

March 3 Venture Roundup: Bionaut debuts with $20M; plus Janux, Century, Caribou, Medilink, Oxular and more

...Bioscience Capital, Avidity Partners, Invus, Janus Henderson, LifeSci Venture Partners, The Leukemia & Lymphoma Society, Monashee Investment Management...
BioCentury | Nov 25, 2020
Product Development

Nov. 25 Quick Takes: FDA approves Y-mAbs’ Danyelza; plus NIH’s ACTT-4; COVAXX, Urovant, SomaLogic, Eluminex and Liquidia

...Science Advisors, Madryn Asset Management, the Fiscus Ventures and Reimagined Ventures affiliates of Magnetar Capital, Monashee Investment Management...
BioCentury | Oct 21, 2020
Deals

With roots in Medivation, Nuvation finds quick route to listing via year’s largest SPAC deal

...Nuvation’s PIPE include new investors 683 Capital, Ally Bridge, Avidity Partners, Deerfield Management, Irving Investors, Monashee Investment Management...
BioCentury | Aug 19, 2020
Finance

Aug. 18 Quick Takes: Chinook fuels up for NASDAQ liftoff; plus Kymera, Poseida, Albireo

...include EcoR1 Capital, OrbiMed Advisors, Rock Springs Capital, Avidity Partners, Surveyor Capital, Ally Bridge Group, Monashee Investment Management...
BioCentury | Nov 24, 2014
Financial News

BioNano Genomics completes venture financing

...Type: Venture financing Raised: $53 million Investors: Legend Capital; Novartis Venture Funds; Federated Kaufmann Fund; Monashee Investment Management...
BioCentury | Nov 21, 2014
Financial News

BioNano raises $53M in series C

...investors Legend Capital and Novartis Venture Fund. Other new investors included Federated Kaufmann Fund and Monashee Investment Management...
Items per page:
1 - 6 of 6
BioCentury | Mar 3, 2021
Finance

March 3 Venture Roundup: Bionaut debuts with $20M; plus Janux, Century, Caribou, Medilink, Oxular and more

...Bioscience Capital, Avidity Partners, Invus, Janus Henderson, LifeSci Venture Partners, The Leukemia & Lymphoma Society, Monashee Investment Management...
BioCentury | Nov 25, 2020
Product Development

Nov. 25 Quick Takes: FDA approves Y-mAbs’ Danyelza; plus NIH’s ACTT-4; COVAXX, Urovant, SomaLogic, Eluminex and Liquidia

...Science Advisors, Madryn Asset Management, the Fiscus Ventures and Reimagined Ventures affiliates of Magnetar Capital, Monashee Investment Management...
BioCentury | Oct 21, 2020
Deals

With roots in Medivation, Nuvation finds quick route to listing via year’s largest SPAC deal

...Nuvation’s PIPE include new investors 683 Capital, Ally Bridge, Avidity Partners, Deerfield Management, Irving Investors, Monashee Investment Management...
BioCentury | Aug 19, 2020
Finance

Aug. 18 Quick Takes: Chinook fuels up for NASDAQ liftoff; plus Kymera, Poseida, Albireo

...include EcoR1 Capital, OrbiMed Advisors, Rock Springs Capital, Avidity Partners, Surveyor Capital, Ally Bridge Group, Monashee Investment Management...
BioCentury | Nov 24, 2014
Financial News

BioNano Genomics completes venture financing

...Type: Venture financing Raised: $53 million Investors: Legend Capital; Novartis Venture Funds; Federated Kaufmann Fund; Monashee Investment Management...
BioCentury | Nov 21, 2014
Financial News

BioNano raises $53M in series C

...investors Legend Capital and Novartis Venture Fund. Other new investors included Federated Kaufmann Fund and Monashee Investment Management...
Items per page:
1 - 6 of 6